FASLG and neoplasm: Regulatory B cells inhibit CD4+ T cells, CTLs, macrophages, and DCs by secreting inhibitory cytokines such as IL10, TGF-β, IL35, and expressing membrane surface regulatory molecules such as FasL and CD1d, and promote the transformation of T cells into Tregs, thus weakening anti-tumor immune responses (96).